Mechanism of regulation and suppression of melanoma invasiveness by novel retinoic acid receptor-γ target gene carbohydrate sulfotransferase 10

Cancer Research

Volumn 69, Issue 12, 2009, Pages 5218-5225

  Zhao, Xiansi ^a   Graves, Carole ^b   Ames, Sarah J ^b   Fisher, David E ^a   Spanjaard, Remco A ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 ANTHRACENYL) 4 THIOPHENE CARBOXYLIC ACID; 4 (3,5,5,8,8 PENTAMETHYL 5,6,7,8 TETRAHYDRO 2 NAPHTHYLTHIO)BENZOIC ACID; 4 [(5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CARBOXAMIDO]BENZOIC ACID; 4 [1 HYDROXY 1 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 2 PROPENYL]BENZOIC ACID; ANTINEOPLASTIC AGENT; CD 2314; CD 666; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR GAMMA; SULFOTRANSFERASE; SULFOTRANSFERASE 10; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; DNA RESPONSIVE ELEMENT; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; INSECT CELL; MELANOMA; MELANOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DNA; HUMANS; MELANOMA; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; PROMOTER REGIONS, GENETIC; RECEPTORS, RETINOIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SULFOTRANSFERASES;

EID: 67449116598     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-0705     Document Type: Article

References (50)

1. Chambon P. The retinoid signaling pathway: molecular and genetic analyses. Semin Cell Biol 1994;5:115-125 (Pubitemid 124003277)
2. Glass CK, Rosenfeld MG, Rose DW, et al. Mechanisms of transcriptional activation by retinoic acid receptors. Biochem Soc Trans 1997;25:602-605 (Pubitemid 27260880)
3. Morriss-Kay GM, Ward SJ. Retinoids and mammalian development. Rev Cytol 1999;188:73-131.
4. Mongan NP, Gudas LJ. Diverse actions of retinoid receptors in cancer prevention and treatment. Differentiation 2007;75:853-870 (Pubitemid 350086170)
5. Niles RM. Signaling pathways in retinoid chemoprevention and treatment of cancer. Mutat Res 2004;555:81-96. (Pubitemid 39359177)
6. Nagpal S, Saunders M, Kastner P, Durand B, Nakshatri H, Chambon P. Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors. Cell 1992;70:1007-1019
7. Lonard DM, O'Malley BW. The expanding cosmos of nuclear receptor coactivators. Cell 2006;125:411-414
8. Lohnes D, Kastner P, Dierich A, Mark M, LeMeur M, Chambon P. Function of retinoic acid receptor γ in the mouse. Cell 1993;73:643-658 (Pubitemid 23159005)
9. Lufkin T, Lohnes D, Mark M, et al. High postnatal lethality and testis degeneration in retinoic acid receptor α mutant mice. Proc Natl Acad Sci U S A 1993;90:7225-7229 (Pubitemid 23222422)
10. Mendelsohn C, Mark M, Dolle P, et al. Retinoic acid receptor β2 (RARβ2) null mutant mice appear normal. Dev Biol 1994;166:246-258 (Pubitemid 24374762)
11. Spanjaard RA, Ikeda M, Lee PJ, Charpentier B, Chin WW, Eberlein TJ. Specific activation of retinoic acid receptors (RARs) and retinoid X receptors reveals a unique role for RARγ in induction of differentiation and apoptosis of S91 melanoma cells. J Biol Chem 1997;272:18990-18999 (Pubitemid 27318254)
12. Moasser MM, Reuter VE, Dmitrovsky E. Overexpression of the retinoic acid receptor γ directly induces terminal differentiation of human embryonal carcinoma cells. Oncogene 1995;10:1537-1543
13. Boylan JF, Lohnes D, Taneja R, Chambon P, Gudas LJ. Loss of retinoic acid receptor γ function in F9 cells by gene disruption results in aberrant Hoxa-1 expression and differentiation upon retinoic acid treatment. Proc Natl Acad Sci U S A 1993;90:9601-9605 (Pubitemid 23315833)
14. Boylan JF, Lufkin T, Achkar CC, Taneja R, Chambon P, Gudas LJ. Targeted disruption of retinoic acid receptor α (RARα) and RARγ results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism. Mol Cell Biol 1995;15:843-851
15. Taneja R, Bouillet P, Boylan JF, et al. Reexpression of retinoic acid receptor (RAR) γ or overexpression of RARα or RARβ in RARγ-null F9 cells reveals a partial functional redundancy between the three RAR types. Proc Natl Acad Sci U S A 1995;92:7854-7858
16. Su D, Gudas LJ. Gene expression profiling elucidates a specific role for RARγ in the retinoic acid-induced differentiation of F9 teratocarcinoma stem cells. Biochem Pharmacol 2008;75:1129-1160
17. Walkley CR, Olsen GH, Dworkin S, et al. A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor deficiency. Cell 2007;129:1090-1110 (Pubitemid 46908696)
18. Bigliardi-Qi M, Miescher GC, Steck AJ. Recognition of human recombinant myelin associated glycoprotein by anti-carbohydrate antibodies of the L2/HNK-1 family. Biochem Biophys Res Commun 1995;217:171-178 (Pubitemid 26004776)
19. Kakuda S, Sato Y, Tonoyama Y, Oka S, Kawasaki T. Different acceptor specificities of two glucuronyltransferases involved in the biosynthesis of HNK-1 carbohydrate. Glycobiology 2005;15:203-210 (Pubitemid 40227924)
20. Ong E, Yeh JC, Ding Y, Hindsgaul O, Fukuda M. Expression cloning of a human sulfotransferase that directs the synthesis of the HNK-1 glycan on the neural cell adhesion molecule and glycolipids. J Biol Chem 1998;273:5190-5195 (Pubitemid 28108681)
21. Senn C, Kutsche M, Saghatelyan A, et al. Mice deficient for the HNK-1 sulfotransferase show alterations in synaptic efficacy and spatial learning and memory. Mol Cell Neurosci 2002;20:712-729
22. Zhao X, Patton JR, Davis SL, Florence B, Ames SJ, Spanjaard RA. Regulation of nuclear receptor activity by a pseudouridine synthase through posttranscriptional modification of steroid receptor RNA activator. Mol Cell 2004;15:549-558 (Pubitemid 39141782)
23. Zhao X, Patton JR, Ghosh SK, Fischel-Ghodsian N, Shen L, Spanjaard RA. Pus3p and Pus1p-dependent pseudouridylation of steroid receptor RNA activator controls a functional switch that regulates nuclear receptor signaling. Mol Endocrinol 2007;21:686-699 (Pubitemid 46310190)
24. Motoyama J, Eto K. Antisense retinoic acid receptor γ-1 oligonucleotide enhances chondrogenesis of mouse limb mesenchymal cells in vitro. FEBS Lett 1994;338:319-322 (Pubitemid 24056744)
25. Srivastava RKA, Schonfeld GMeasurements of rate of transcription in isolated nuclei by nuclear "run-off" assay. In: Harwood AJ, editor. Protocols for gene analysis, series: methods in molecular biology. Cambridge (United Kingdom): Springer Science + Business Media; 1994. 31. p. 281-288
26. Elmazar MM, Ruhl R, Reichert U, Shroot B, Nau H. RARα-mediated teratogenicity in mice is potentiated by an RXR agonist and reduced by an RAR antagonist: dissection of retinoid receptor-induced pathways. Toxicol Appl Pharmacol 1997;146:21-28 (Pubitemid 27406393)
27. Minucci S, Leid M, Toyama R, et al. Retinoid X receptor (RXR) within the RXR-retinoic acid receptor heterodimer binds its ligand and enhances retinoid-dependent gene expression. Mol Cell Biol 1997;17:644-655 (Pubitemid 27044364)
28. Schrader M, Wyss A, Sturzenbecker LJ, Grippo JF, LeMotte P, Carlberg C. RXR-dependent and RXR-independent transactivation by retinoic acid receptors. Nucleic Acids Res 1993;21:1231-1237 (Pubitemid 23155621)
29. Ferrari N, Pfahl M, Levi G. Retinoic acid receptor γ1 (RARγ1) levels control RARβ2 expression in SK-N-BE2 (c) neuroblastoma cells and regulate a differentiation-apoptosis switch. Mol Cell Biol 1998;18:6482-6492 (Pubitemid 28500538)
30. Husmann M, Lehmann J, Hoffmann B, Hermann T, Tzukerman M, Pfahl M. Antagonism between retinoic acid receptors. Mol Cell Biol 1991;11:4097-4103 (Pubitemid 21895799)
31. Taneja R, Roy B, Plassat JL, et al. Cell-type and promoter-context dependent retinoic acid receptor (RAR) redundancies for RARβ2 and Hoxa-1activation in F9 and P19 cells can be artefactually generated by gene knockouts. Proc Natl Acad Sci U S A 1996;93:6197-6202 (Pubitemid 26190827)
32. Demary K, Wong L, Spanjaard RA. Effects of retinoic acid and sodium butyrate on gene expression, histone acetylation and inhibition of proliferation of melanoma cells. Cancer Lett 2001;163:103-108 (Pubitemid 32121835)
33. Mooy CM, Luyten GP, de Jong PT, et al. Neural cell adhesion molecule distribution in primary and metastatic uveal melanoma. Hum Pathol 1995;26:1185-1190
34. Shih L-M, Elder DE, Speicher D, Johnson JP, Herlyn M. Isolation and functional characterization of the A32 melanoma-associated antigen. Cancer Res 1994;54:2514-2520 (Pubitemid 24138750)
35. Tang NE, Luyten GP, Mooy CM, Naus NC, de Jong PT, Luider TM. HNK-1 antigens on uveal and cutaneous melanoma cell lines. Melanoma Res 1996;6:411-418 (Pubitemid 27008295)
36. Casado JG, Delgado E, Patsavoudi E, et al. Functional implications of HNK-1 expression on invasive behaviour of melanoma cells. Tumour Biol 2008;29:304-310
37. Robertson KA, Emami B, Mueller L, Collins SJ. Multiple members of the retinoic acid receptor family are capable of mediating the granulocytic differentiation of HL-60 cells. Mol Cell Biol 2000;12:3743-3749
38. Collins SJ, Robertson KA, Mueller L. Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RARα). Mol Cell Biol 1990;10:2154-2163 (Pubitemid 20138837)
39. Drach J, McQueen T, Engel H, et al. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptorα. Cancer Res 1994;54:1746-1752 (Pubitemid 24116180)
40. Han GR, Dohi DF, Lee HY, et al. All-trans-retinoic acid increases transforming growth factor-β2 and insulin-like growth factor binding protein-3 expression through a retinoic acid receptor-α-dependent signaling pathway. J Biol Chem 1997;272:13711-13716 (Pubitemid 27224806)
41. Zhang LX, Mills KJ, Dawson MI, Collins SJ, Jetten AM. Evidence for the involvement of retinoic acid receptor RARα-dependent signaling pathway in the induction of tissue transglutaminase and apoptosis by retinoids. J Biol Chem 1995;270:6022-6029
42. Epping MT, Wang L, Plumb JA, et al. Functional genetic screen identifies retinoic acid signaling as a target of histone deacetylase inhibitors. Proc Natl Acad Sci U S A 2007;104:17777-17782 (Pubitemid 350210911)
43. Lou YR, Miettinen S, Kagechika H, Gronemeyer H, Tuohimaa P. Retinoic acid via RARα inhibits the expression of 24-hydroxylase in human prostate stromal cells. Biochem Biophys Res Commun 2005;338:1973-1981 (Pubitemid 41643115)
44. Nicke B, Kaiser A, Wiedenmann B, Riecken EO, Rosewicz S. Retinoic acid receptor α mediates growth inhibition by retinoids in human colon carcinoma HT29 cells. Biochem Biophys Res Commun 1999;261:572-577 (Pubitemid 29408100)
45. Liu Y, Lee MO, Wang HG, et al. Retinoic acid receptor β mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol Cell Biol 1996;16:1138-1149 (Pubitemid 26061685)
46. Marshall GM, Cheung B, Stacey KP, et al. Increased retinoic acid receptor γ expression suppresses the malignant phenotype and alters the differentiation potential of human neuroblastoma cells. Oncogene 1995;11:485-491
47. Kizuka Y, Matsui T, Takematsu H, Kozutsumi Y, Kawasaki T, Oka S. Physical and functional association of glucuronyltransferases and sulfotransferase involved in HNK-1 biosynthesis. J Biol Chem 2006;281:13644-13651 (Pubitemid 43855280)
48. Valyi-Nagy I, Hirka O, Jensen PJ, Shih L-M, Juhasz I, Herlyn M. Undifferentiated keratinocytes control growth, morphology and antigen expression of normal melanocytes through cell-cell contact. Lab Invest 1993;69:152-159 (Pubitemid 23262495)
49. Thies A, Schachner M, Berger J, et al. The developmentally regulated neural crest-associated glycotope HNK-1 predicts metastasis in cutaneous malignant melanoma. J Pathol 2004;203:933-939 (Pubitemid 39089282)
50. Sondak VK, Liu PY, Flaherty LE, et al. A phase II evaluation of all-trans-retinoic acid plus interferon α-2a in stage IV melanoma: a Southwest Oncology Group study. Cancer J Sci Am 1999;5:41-47 (Pubitemid 29108645)